Metformin protects prepubertal mice ovarian reserve against cyclophosphamide via regulation of the PI3K/Akt/mTOR signaling pathway and Yap-1
2024

Metformin Protects Ovarian Reserve in Mice from Chemotherapy Damage

Sample size: 24 publication 10 minutes Evidence: high

Author Information

Author(s): Zatalian Negin, Dalman Azam, Afsharian Parvaneh, Hezavehei Maryam, Gourabi Hamid

Primary Institution: University of Science and Culture and Royan Institute

Hypothesis

Does metformin mitigate the ovarian damage caused by cyclophosphamide in prepubertal mice?

Conclusion

Metformin can help preserve ovarian function in mice treated with cyclophosphamide by regulating key signaling pathways.

Supporting Evidence

  • Metformin increased AMH levels in treated mice.
  • Metformin reduced the activation of primordial follicles.
  • Metformin improved ovarian volume compared to cyclophosphamide treatment alone.
  • Metformin modulated the expression of genes in the PI3K/Akt/mTOR pathway.

Takeaway

Metformin is like a superhero for young mice's ovaries, helping them stay healthy even when they get a medicine that usually makes them sick.

Methodology

The study involved 24 prepubertal female mice divided into four groups, with treatments including metformin and cyclophosphamide, followed by analysis of ovarian health.

Limitations

The study was conducted on mice, which may not fully replicate human responses to chemotherapy and metformin.

Participant Demographics

14-day-old NMRI female mice

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s13048-024-01572-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication